Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Non-cash Items (2021 - 2025)

Historic Non-cash Items for Organogenesis Holdings (ORGO) over the last 5 years, with Q3 2025 value amounting to $6.3 million.

  • Organogenesis Holdings' Non-cash Items rose 1377.34% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year increase of 1377.34%. This contributed to the annual value of $2.5 million for FY2024, which is 3696.52% down from last year.
  • Organogenesis Holdings' Non-cash Items amounted to $6.3 million in Q3 2025, which was up 1377.34% from $6.4 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Non-cash Items registered a high of $38.5 million during Q4 2021, and its lowest value of $2.2 million during Q4 2022.
  • Over the past 5 years, Organogenesis Holdings' median Non-cash Items value was $5.5 million (recorded in 2024), while the average stood at $7.8 million.
  • As far as peak fluctuations go, Organogenesis Holdings' Non-cash Items tumbled by 9417.25% in 2022, and later surged by 35732.74% in 2023.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Non-cash Items stood at $38.5 million in 2021, then crashed by 94.17% to $2.2 million in 2022, then skyrocketed by 357.33% to $10.3 million in 2023, then tumbled by 75.45% to $2.5 million in 2024, then skyrocketed by 148.94% to $6.3 million in 2025.
  • Its Non-cash Items was $6.3 million in Q3 2025, compared to $6.4 million in Q2 2025 and $12.6 million in Q1 2025.